Plain Language Summaries is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • How to
  • FAQs
  • Publications
  • Advisory Panel
    • Plain Language Advisors
    • Scientific Content Advisors
  • Supporters
  • Blog
  • About us
  • Contact Us

Vaccines

28th Oct 2025

Plain language summary of adult Lyme disease vaccine booster trial

23rd Apr 2025

A plain language summary of responses to common misconceptions relating to updated COVID-19 mRNA vaccines

23rd Apr 2025

Plain language summary of safety data on the BNT162b2 COVID-19 vaccine: development, approval and ongoing monitoring

22nd Jan 2025

Plain language summary of how COVID-19 treatment with ritonavir may interact with other medications

21st Jan 2025

Plain language summary: Challenges and use of injectable medications in Hospital-at-Home care

The PLSP summarizes results from the phase 2/3 KidCOVE trial examining mRNA-1273 (Moderna’s COVID-19 vaccine) in children 6 through 11 years of age.
28th Jul 2023

Plain Language Summary: evaluating Moderna’s COVID-19 vaccine in children ages 6 to 11

28th Nov 2022

Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older

20th Sep 2022

A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster

1st Nov 2021

A plain language summary of how well the single-dose Janssen vaccine works and how safe it is

Copyright © 2026 · Plain Language Summaries · Terms and conditions · Privacy policy · Cookie policy